HOOK - Catalyst on 23/05/2024HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and The
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.5494 USD
−43.50 M USD
43.95 M USD
6.88 M
About HOOKIPA Pharma Inc.
Sector
Industry
CEO
Malte Peters
Website
Headquarters
New York
Founded
2011
FIGI
BBG00NGMNKR4
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. It also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.
HOOKIPA Pharma (USA: $HOOK) Look For An Imminent Eruption! 🌋HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II cli
HOOKIPA Pharma Inc 🧙HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and The
HOOK General/Rough Short Position Analysis Overall:
* Negative EPS
* June 7th conference @ASCO will most likely lead to a double-top.
* The "surge" is starting to end, if not has already ended. Share price should return to anywhere between $8-11, possibly even lower.
* Medical breakthroughs, as a whole, when it comes to cancers, which this
Hookia Pharma Soars on early stage FDA approval +++++++ HOT STOCK FOR FRIDAY +++++++++
Shares of Hookipa Pharma Inc. (HOOK) surged in after-hours trading Thursday after the company said the FDA approved an early stage trial of its treatment for human papilloma virus (HPV)-positive cancers.
The stock rose $2.46, or 37% to $9.14 in after-hours acti
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of HOOK is 0.7733 USD — it hasn't changed in the past 24 hours. Watch HOOKIPA Pharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HOOKIPA Pharma Inc. stocks are traded under the ticker HOOK.
HOOK stock has fallen by −0.86% compared to the previous week, the month change is a −34.47% fall, over the last year HOOKIPA Pharma Inc. has showed a −90.45% decrease.
We've gathered analysts' opinions on HOOKIPA Pharma Inc. future price: according to them, HOOK price has a max estimate of 7.00 USD and a min estimate of 2.00 USD. Watch HOOK chart and read a more detailed HOOKIPA Pharma Inc. stock forecast: see what analysts think of HOOKIPA Pharma Inc. and suggest that you do with its stocks.
HOOK reached its all-time high on May 18, 2021 with the price of 200.0000 USD, and its all-time low was 0.7210 USD and was reached on Apr 9, 2025. View more price dynamics on HOOK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HOOK stock is 4.77% volatile and has beta coefficient of 1.73. Track HOOKIPA Pharma Inc. stock price on the chart and check out the list of the most volatile stocks — is HOOKIPA Pharma Inc. there?
Today HOOKIPA Pharma Inc. has the market capitalization of 9.33 M, it has increased by 0.89% over the last week.
Yes, you can track HOOKIPA Pharma Inc. financials in yearly and quarterly reports right on TradingView.
HOOKIPA Pharma Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
HOOK earnings for the last quarter are −1.95 USD per share, whereas the estimation was −1.12 USD resulting in a −73.59% surprise. The estimated earnings for the next quarter are −1.04 USD per share. See more details about HOOKIPA Pharma Inc. earnings.
HOOKIPA Pharma Inc. revenue for the last quarter amounts to 1.34 M USD, despite the estimated figure of 3.44 M USD. In the next quarter, revenue is expected to reach 3.38 M USD.
HOOK net income for the last quarter is −24.95 M USD, while the quarter before that showed −13.84 M USD of net income which accounts for −80.26% change. Track more HOOKIPA Pharma Inc. financial stats to get the full picture.
No, HOOK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 20, 2025, the company has 87 employees. See our rating of the largest employees — is HOOKIPA Pharma Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOOKIPA Pharma Inc. EBITDA is −42.03 M USD, and current EBITDA margin is −95.65%. See more stats in HOOKIPA Pharma Inc. financial statements.
Like other stocks, HOOK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOOKIPA Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOOKIPA Pharma Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOOKIPA Pharma Inc. stock shows the sell signal. See more of HOOKIPA Pharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.